Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
CollaGenex
>
Is Arestin kicking your ASS?
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 18326"]Don't both products result in improved pocket depth reduction? And you can't have improvements in pocket depth reduction without gains in clinical attachment since these two paramaters are related, right? It is easy to see then that Arestin must also result in gains in clinical attachment (which is exactly what dentists have pointed out to me).</p><p><br /></p><p>And regarding our claim that 'Atridox gets deeper in the pocket so it must be better at killing the bad bacteria'--isn't a pocket a single, continuous space? If it isn't then how are we able to measure the concentration of Atridox within the pocket (follow your own advice and check the training binder); in the PI we talk about the levels of doxy in the pocket but don't specify if this concentration is in the bottom, middle, or top of the pocket. So does it really matter? Again, a DDS explained this to me by saying, "Picture a pocket like a glass of water, whatever you put in there ends up getting distributed throughout the entire pocket eventually."</p><p><br /></p><p>Look, I'm sure that you hear these same objections from your docs and I'm just very frustrated b/c when I trot these answers out that aren't supported by good science, I lose credibility--and HQ doesn't seem to have the answers either.</p><p><br /></p><p>...and yes, I am getting my ass kicked.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 18326"]Don't both products result in improved pocket depth reduction? And you can't have improvements in pocket depth reduction without gains in clinical attachment since these two paramaters are related, right? It is easy to see then that Arestin must also result in gains in clinical attachment (which is exactly what dentists have pointed out to me). And regarding our claim that 'Atridox gets deeper in the pocket so it must be better at killing the bad bacteria'--isn't a pocket a single, continuous space? If it isn't then how are we able to measure the concentration of Atridox within the pocket (follow your own advice and check the training binder); in the PI we talk about the levels of doxy in the pocket but don't specify if this concentration is in the bottom, middle, or top of the pocket. So does it really matter? Again, a DDS explained this to me by saying, "Picture a pocket like a glass of water, whatever you put in there ends up getting distributed throughout the entire pocket eventually." Look, I'm sure that you hear these same objections from your docs and I'm just very frustrated b/c when I trot these answers out that aren't supported by good science, I lose credibility--and HQ doesn't seem to have the answers either. ...and yes, I am getting my ass kicked.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
CollaGenex
>
Is Arestin kicking your ASS?
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
CollaGenex
>
Is Arestin kicking your ASS?
>